# Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia

> **NCT06606886** · PHASE4 · COMPLETED · sponsor: **Bahria University** · enrollment: 96 (actual)

## Conditions studied

- Transfusion Dependent Beta-thalassemia

## Interventions

- **DRUG:** Tablet Metformin (Group A)
- **DRUG:** Tablet Hydroxyurea (Group B)

## Key facts

- **NCT ID:** NCT06606886
- **Lead sponsor:** Bahria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-16
- **Primary completion:** 2026-02-09
- **Final completion:** 2026-02-09
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06606886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06606886, "Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06606886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*